Announcements Trials
Browse Landscape

Phase

Phase 2 22Phase 3 9Phase 4 2Phase NA 1Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 1

Interventions

Radiotherapy 26Standard of Care 25Surveys and Questionnaires 22Blood Specimen Collection 21Cisplatin 20Radiotherapy, Intensity-Modulated 19Magnetic Resonance Spectroscopy 19Biopsy 15Practice Guidelines as Topic 13Low-Level Light Therapy 13Exercise 10X-Rays 9Surgical Procedures, Operative 9Radiosurgery 9Interviews as Topic 9Therapeutics 8Magnetic Resonance Imaging 8Saline Solution 7Radiofrequency Ablation 7Radiation 7Fluorodeoxyglucose F18 7Transcutaneous Electric Nerve Stimulation 6Thyroidectomy 6Immunohistochemistry 6Educational Status 6Control Groups 6Chemoradiotherapy 6Cetuximab 6Biopsy, Fine-Needle 6Acupuncture Therapy 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × nimotuzumab × Head & Neck × Clear all
NCT05717790 2023-02-08

Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma

Fourth Affiliated Hospital of Guangxi Medical University

Phase NA Recruiting
288 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡